# Ricardo Ayala

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ricardo-ayala/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,173 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 12 |
| i10-index | 12 |
| Last Known Institution | Universidad Nacional de Piura |
| OpenAlex ID | https://openalex.org/A5102722273 |
| ORCID iD | 0000-0002-7913-8728 |
| Works | 40 |

## Researcher papers

- [Donanemab in Early Symptomatic Alzheimer Disease](https://scholariq.org/papers/donanemab-in-early-symptomatic-alzheimer-disease/)
- [Adjunctive perampanel for refractory partial-onset seizures](https://scholariq.org/papers/adjunctive-perampanel-for-refractory-partial-onset-seizures/)
- [Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures](https://scholariq.org/papers/double-blind-placebo-controlled-trial-of-adjunctive-levetiracetam-in-pediatric/)
- [Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial](https://scholariq.org/papers/continuation-versus-discontinuation-of-renin-angiotensin-system-inhibitors-in/)
- [Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures](https://scholariq.org/papers/randomized-controlled-trial-of-zonisamide-for-the-treatment-of-refractory/)
- [Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy](https://scholariq.org/papers/higher-androgens-and-weight-gain-with-valproate-compared-with-lamotrigine-for/)
- [Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy](https://scholariq.org/papers/efficacy-and-safety-of-xen1101-a-novel-potassium-channel-opener-in-adults-with/)
- [Características clínicoepidemiológicas de pacientes fallecidos por COVID-19 en un hospital nacional de Lima, Perú](https://scholariq.org/papers/caracteristicas-clinicoepidemiologicas-de-pacientes-fallecidos-por-covid-19-en/)
- [Long-term Tolerability and Efficacy of Lamotrigine in Infants 1 to 24 Months Old](https://scholariq.org/papers/long-term-tolerability-and-efficacy-of-lamotrigine-in-infants-1-to-24-months-old/)
- [A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019](https://scholariq.org/papers/a-randomized-clinical-trial-of-lipid-metabolism-modulation-with-fenofibrate-for/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

## Researcher university

- [Universidad Nacional de Piura](https://scholariq.org/institutions/universidad-nacional-de-piura/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.